Medicare
The 340B Drug Pricing Program “has enabled hospitals and health systems to support and expand access and services consistent with their mission and the program’s original and ongoing charge,” the AHA and Association of American Medical Colleges today told leaders of the House Energy and Commerce…
The Centers for Medicare & Medicaid Services today officially withdrew its proposal to test new models for how Medicare Part B pays for prescription drugs provided in physician offices and hospital outpatient departments.
The Centers for Medicare & Medicaid Services Friday released premium and cost information for Medicare Advantage and Part D prescription drug plans for the 2018 calendar year.
Once again, the Senate attempted to pass a proposal to repeal and replace significant parts of the Affordable Care Act. Once again, it met defeat – and we are grateful.But this fight is not over. America’s hospitals and health systems must stay vigilant and continue to make the case to protect…
On Sept. 6, the CMS' Survey and Certification (S&C) Group released guidance clarifying how it will determine whether a facility qualifies as a hospital under Section 1861(e)(1) of the Social Security Act.
Two hundred twenty-eight members of the House of Representatives yesterday urged the Centers for Medicare & Medicaid Services to abandon its proposal to reduce Medicare Part B payment for drugs acquired through the 340B Drug Pricing Program.
The Health Resources and Services Administration today delayed to July 1, 2018 the effective date of its final rule on 340B drug ceiling prices and civil monetary penalties for manufacturers. “We are delaying the effective date of the Jan.
A bipartisan group of 228 House lawmakers yesterday urged the Centers for Medicare & Medicaid Services (CMS) to abandon its proposal to reduce Medicare Part B payment for drugs acquired through the 340B Drug Pricing Program.
Are you ready for the Medicare Access and CHIP Reauthorization Act or MACRA? The AHA’s MACRA resources are designed to support your needs as you implement MACRA’s sweeping changes.Our latest offering aims to help you and your clinician partners decide which MACRA track to pursue – the Merit-based…